Aldosterone
Aldosterone damages the vasculature, heart, and kidneys
Published in Heart Disease Weekly, July 17th, 2005
According to the report from the United States, "This review highlights recent clinical studies demonstrating; the contribution of aldosterone to cardiovascular mortality, dysfunction, and renal injury in the context of in our understanding of the molecular biology of aldosterone."
N.J. Brown and colleagues of Vanderbilt University wrote, "Mineralocorticoid receptor antagonism reduces mortality in patients with congestive heart failure and following myocardial infarction. Studies in animal models and in patients with congestive heart failure or hypertension indicate that aldosterone...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
Source: Heart Disease Weekly (2005-07-17)
More Articles from Heart Disease Weekly
- Atrial Fibrillation
ACE inhibitors prevent progression from paroxysmal AF to chronic AF - Cardiac Surgery
Epiaortic ultrasonography should be used routinely in cardiac surgery - Cardioprotection
Inhibiting Na+-Ca2+ exchanger during I/R is cardioprotective - Heart Failure
Elevated serum creatinine had a linear association with risk in cardiac patients - Ventricular Repolarization
Study found gender differences in T-wave morphology dispersion - Alcohol Use
Article discusses the mechanisms of alcohol's effect on cardiac mitochondria - More from this issue of Heart Disease Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
